Ling Gabriel has filed 5 insider transactions across 1 company since December 2023.
Most recent transaction: a grant/award of 46296 shares of Oncology Institute, Inc. ($TOI) on November 20, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2025 | Oncology Institute, Inc. | $TOI | Ling Gabriel | Director | A | Common Stock | 46296 | $0.00 | 296,502.0000 | 99,303,511 | 18.50% | 0.05% |
| Nov. 20, 2025 | Oncology Institute, Inc. | $TOI | Ling Gabriel | Director | A | Common Stock | 37037 | $0.00 | 333,539.0000 | 99,303,511 | 12.49% | 0.04% |
| Nov. 18, 2025 | Oncology Institute, Inc. | $TOI | Ling Gabriel | Director | J | Common Stock | 141149 | $0.00 | 250,206.0000 | 99,303,511 | 129.43% | 0.14% |
| Nov. 22, 2024 | Oncology Institute, Inc. | $TOI | Ling Gabriel | Director | A | Common stock | 40000 | $0.00 | 109,057.0000 | 77,292,849 | 57.92% | 0.05% |
| Dec. 26, 2023 | Oncology Institute, Inc. | $TOI | Ling Gabriel | Director | A | Common stock | 40000 | $0.00 | 69,057.0000 | 73,265,621 | 137.66% | 0.05% |